FI20010115A0 - Menetelmä nanopartikkelien valmistamiseksi - Google Patents

Menetelmä nanopartikkelien valmistamiseksi

Info

Publication number
FI20010115A0
FI20010115A0 FI20010115A FI20010115A FI20010115A0 FI 20010115 A0 FI20010115 A0 FI 20010115A0 FI 20010115 A FI20010115 A FI 20010115A FI 20010115 A FI20010115 A FI 20010115A FI 20010115 A0 FI20010115 A0 FI 20010115A0
Authority
FI
Finland
Prior art keywords
particles
droplets
carrier gas
liquid feed
feed stock
Prior art date
Application number
FI20010115A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Wiwik Watanabe
Esko Kauppinen
Petri Ahonen
David Brown
Esa Muttonen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Priority to FI20010115A priority Critical patent/FI20010115A0/fi
Publication of FI20010115A0 publication Critical patent/FI20010115A0/fi
Priority to PCT/FI2002/000042 priority patent/WO2002056866A1/en
Priority to AT02710900T priority patent/ATE387185T1/de
Priority to EP02710900A priority patent/EP1351666B1/de
Priority to DE60225242T priority patent/DE60225242T2/de
Priority to US10/466,365 priority patent/US20040091542A1/en
Priority to JP2002557374A priority patent/JP4728558B2/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0004—Preparation of sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI20010115A 2001-01-18 2001-01-18 Menetelmä nanopartikkelien valmistamiseksi FI20010115A0 (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20010115A FI20010115A0 (fi) 2001-01-18 2001-01-18 Menetelmä nanopartikkelien valmistamiseksi
PCT/FI2002/000042 WO2002056866A1 (en) 2001-01-18 2002-01-18 A method for the preparation of nanoparticles
AT02710900T ATE387185T1 (de) 2001-01-18 2002-01-18 Verfahren zur herstellung von nanopartikeln
EP02710900A EP1351666B1 (de) 2001-01-18 2002-01-18 Verfahren zur herstellung von nanopartikeln
DE60225242T DE60225242T2 (de) 2001-01-18 2002-01-18 Verfahren zur herstellung von nanopartikeln
US10/466,365 US20040091542A1 (en) 2001-01-18 2002-01-18 Method for the preparation of nanoparticles
JP2002557374A JP4728558B2 (ja) 2001-01-18 2002-01-18 ナノ粒子の製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20010115A FI20010115A0 (fi) 2001-01-18 2001-01-18 Menetelmä nanopartikkelien valmistamiseksi

Publications (1)

Publication Number Publication Date
FI20010115A0 true FI20010115A0 (fi) 2001-01-18

Family

ID=8560060

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20010115A FI20010115A0 (fi) 2001-01-18 2001-01-18 Menetelmä nanopartikkelien valmistamiseksi

Country Status (7)

Country Link
US (1) US20040091542A1 (de)
EP (1) EP1351666B1 (de)
JP (1) JP4728558B2 (de)
AT (1) ATE387185T1 (de)
DE (1) DE60225242T2 (de)
FI (1) FI20010115A0 (de)
WO (1) WO2002056866A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US6900317B2 (en) 2002-02-19 2005-05-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
ATE510174T1 (de) 2003-05-21 2011-06-15 Alexza Pharmaceuticals Inc Schlag gezündete unabhängige heizeinheit
US20070142589A1 (en) * 2004-02-24 2007-06-21 Rogers Martin E Process and systems for the efficient production of polymeric microspheres
ES2391626T3 (es) * 2004-05-04 2012-11-28 Hormos Medical Ltd. Nuevas composiciones orales de ospemifeno
US8758821B2 (en) 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
WO2006069419A1 (en) * 2004-12-31 2006-07-06 Iceutica Pty Ltd Nanoparticle composition and methods for synthesis thereof
JP4979203B2 (ja) * 2005-05-31 2012-07-18 栗田工業株式会社 吸着構造体およびその製造方法
CA2618655C (en) 2005-07-18 2015-12-22 University Of Massachusetts Lowell Compositions and methods for making and using nanoemulsions
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
DK3144013T3 (en) * 2005-12-01 2019-03-04 Univ Massachusetts Lowell Botulinum nanoemulsions
CN1785153B (zh) * 2005-12-06 2010-04-21 青岛大学 纳米级材料制备装置及纳米抗氧化活性多肽药物的制备方法
EP2018875A1 (de) 2006-05-15 2009-01-28 Ebara Corporation Pharmazeutischer wirkstoff mit geringer wasserlöslichkeit
JP2007301534A (ja) 2006-05-15 2007-11-22 Ebara Corp 微細化装置
DE102006026578B4 (de) 2006-06-08 2009-01-08 Lts Lohmann Therapie-Systeme Ag Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung
CA2653384C (en) 2006-06-30 2017-03-14 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form
BRPI0719732A2 (pt) 2006-12-01 2017-05-16 Anterios Inc nanopartículas de peptídeo e usos para as mesmas
BRPI0719756A2 (pt) 2006-12-01 2014-01-21 Anterios Inc Nanopartículas de entidades anfifílicas
JP2010512350A (ja) * 2006-12-11 2010-04-22 ダラグレキュル・アンパルトセルスカブ ホスホマイシンの肺投与により細菌感染を伴う嚢胞性線維症または肺炎を処置するための方法
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
KR20100050443A (ko) 2007-05-31 2010-05-13 안테리오스, 인코퍼레이티드 핵산 나노입자 및 이의 용도
US20110182994A1 (en) * 2008-07-25 2011-07-28 S.K. Pharmaceuticals, Inc. Methods and systems for production of nanoparticles
BRPI1014275B8 (pt) 2009-04-24 2021-05-25 Iceutica Pty Ltd composição que compreende partículas de indometacina dispersas em pelo menos dois materiais de moagem parcialmente moídos
DE102014011635A1 (de) 2013-09-04 2015-03-05 Chemiewerk Bad Köstritz GmbH Verfahren zur Herstellung von nanostrukturierbaren Mikropartikeln aus fluiden Medien mittels Sprühtrocknung
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
US11311496B2 (en) 2016-11-21 2022-04-26 Eirion Therapeutics, Inc. Transdermal delivery of large agents
CN110232214B (zh) * 2019-05-09 2020-07-28 北京大学 一种通过数值模拟的食品预冷性能评估和优化方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3306250A1 (de) * 1983-02-23 1984-08-23 Basf Ag, 6700 Ludwigshafen Sphaerische einkristalle fuer pharmazeutische zwecke
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
NZ248813A (en) * 1992-11-25 1995-06-27 Eastman Kodak Co Polymeric grinding media used in grinding pharmaceutical substances
US5819726A (en) * 1993-01-29 1998-10-13 Aradigm Corporation Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease
US5833892A (en) * 1996-07-12 1998-11-10 Kemira Pigments, Inc. Formation of TiO2 pigment by spray calcination
US6051257A (en) * 1997-02-24 2000-04-18 Superior Micropowders, Llc Powder batch of pharmaceutically-active particles and methods for making same
US6338809B1 (en) * 1997-02-24 2002-01-15 Superior Micropowders Llc Aerosol method and apparatus, particulate products, and electronic devices made therefrom

Also Published As

Publication number Publication date
ATE387185T1 (de) 2008-03-15
DE60225242T2 (de) 2009-03-19
EP1351666B1 (de) 2008-02-27
US20040091542A1 (en) 2004-05-13
DE60225242D1 (de) 2008-04-10
JP2004520157A (ja) 2004-07-08
WO2002056866A1 (en) 2002-07-25
JP4728558B2 (ja) 2011-07-20
EP1351666A1 (de) 2003-10-15

Similar Documents

Publication Publication Date Title
FI20010115A0 (fi) Menetelmä nanopartikkelien valmistamiseksi
Anderson et al. Magnetic functionalized nanoparticles for biomedical, drug delivery and imaging applications
Bian et al. Peptide-directed hierarchical mineralized silver nanocages for anti-tumor photothermal therapy
US10980832B2 (en) Gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
CN101479051B (zh) 生产多层粒子、纤维和喷雾的系统和方法以及施用它们的方法
Raliya et al. Perspective on nanoparticle technology for biomedical use
Baldelli et al. Analysis of the particle formation process of structured microparticles
US8852644B2 (en) Method and device for producing microparticles or nanoparticles
Low et al. Sonoproduction of nanobiomaterials–A critical review
CA2829095A1 (en) Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same
Dheyab et al. Distinct advantages of using sonochemical over laser ablation methods for a rapid-high quality gold nanoparticles production
FI20002217A (fi) Inhalaatiopartikkelit
Soulé et al. Design and cellular fate of bioinspired Au–Ag Nanoshells@ Hybrid silica nanoparticles
JP3740152B2 (ja) 微細ゲル粒子の製造方法および製造装置
Patel et al. Ordered mesoporous silica nanocarriers: An innovative paradigm and a promising therapeutic efficient carrier for delivery of drugs
Chakraborty et al. Nano-dimensional gold synthesis for biomedical applications: upscaling and challenges
Bayer et al. Influence of nanosecond pulsed laser irradiance on the viability of nanoparticle-loaded cells: implications for safety of contrast-enhanced photoacoustic imaging
Brown et al. Advancements in using TiO2 bionanoconjugates for precision degradation of intracellular biological structures
Wang et al. Superparamagnetic Artificial Cells PLGA-Fe3O4 Micro/Nanocapsules for Cancer Targeted Delivery
Zhang et al. Continuous ammonium silicofluoride ammonification for SiO2 nanoparticles preparation in a microchemical system
Shin Low et al. Sonoproduction of nanobiomaterials–A critical review
Khurshid et al. Metallic Nanoparticles for Imaging and Therapy
Ni et al. Enhanced Stability and Photothermal Effect in the rGO/Au-Nanoprisms Hybrids
Movahedi et al. An experimental and numerical study of microfluidic preparation of chitosan nanoparticle
Abd INTERFACE OF GOLD NANOSTRUCTURE FOR MEDICAL APPLICATIONS